CEO
Kevin Huh is CEO of KIMCo,, that provides Open Innovation Platform for co-development & co-investment as non-profit organization funded by 59 Korean pharma and KPBMA, operating with public and private strategic partners, to accelerate industry growth through innovative medicines development. Kevin is leading this strategic operations, collaborating with key stakeholders in Korea and cross-boarders globally.
Kevin brings professional expertise well over 30 years of business leadership experiences in Korea and APAC region, such as Vice-chairman of KPBMA, General Manager of IMS Health, Quintiles (IQVIA) and Knoll Pharma in Korea, as well as Director- business development of PharmaLink APAC in Singapore regional office. Through this multiple leadership roles, he has proven track records of new business development and operation, achieving profitable and sustainable performance as the senior executive in the bio-pharma industry.
Kevin holds MBA from Yonsei University Graduate School and BS in Pharmacy from Seoul National University. He took Management course of Business School in Singapore National University.